Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma-Reference-Cited by-同舟云学术

Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma

Published:2022-08-23 Issue:8 Volume:328 Page:728
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Tang Ling-Long¹,Guo Rui¹,Zhang Ning²,Deng Bin³,Chen Lei¹,Cheng Zhi-Bin⁴,Huang Jing⁵,Hu Wei-Han¹,Huang Shao Hui⁶,Luo Wei-Jun²,Liang Jin-Hui³,Zheng Yu-Ming³,Zhang Fan⁴,Mao Yan-Ping¹,Li Wen-Fei¹,Zhou Guan-Qun¹,Liu Xu¹,Chen Yu-Pei¹,Xu Cheng¹,Lin Li¹,Liu Qing⁷,Du Xiao-Jing¹,Zhang Yuan¹,Sun Ying¹,Ma Jun¹⁸

Affiliation:

1. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China

2. Department of Radiation Oncology, First People’s Hospital of Foshan, Foshan Guangdong, China

3. Department of Radiation Oncology, the Wuzhou Red Cross Hospital, Wuzhou, Guangxi, China

4. Department of Radiation Oncology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China

5. Department of Oncology, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s China

6. Department of Radiation Oncology, Princess Margaret Cancer Centre/University of Toronto, Ontario, Canada

7. Clinical Trials Centre, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, Guangdong, China

8. Center for Precision Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2795527/jama_tang_2022_oi_220089_1660869435.868.pdf

Reference34 articles.

1. Nasopharyngeal cancer: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.;Chan;Ann Oncol,2012

2. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.;Chen;J Natl Cancer Inst,2011

3. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099.;Al-Sarraf;J Clin Oncol,1998

4. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group.;Lee;J Clin Oncol,2005